Trial Profile

T Cell-Reduced Unrelated Donor Allogeneic Peripheral Blood Stem Cell Transplantation With Pentostatin and Low-Dose Total Body Irradiation.

Status: Withdrawn prior to enrolment

Phase of Trial: Phase I/II

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pentostatin (Primary) ; Ciclosporin; Mycophenolate mofetil
Indications Graft-versus-host disease; Haematological malignancies
Focus Adverse reactions; Therapeutic Use

Most Recent Events

24 Jan 2018 Biomarkers information updated
02 Jun 2010 Planned end date changed from 1 Feb 2018 to 1 Feb 2010 as reported by ClinicalTrials.gov.
02 Jun 2010 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com